Aveanna Healthcare Holdings Inc.
AVAHNASDAQHealthcare● Active
$6.68
+$0.05(+0.75%)
Market Cap$1.5B
P/E Ratio—
52W High$10.32
52W Low$3.73
Aveanna Healthcare Holdings Inc. (AVAH) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
AVAH · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 14, 2026EPS Actual
$0.18
Est. $0.13 · +38.5%
Revenue
$0.65B
Est. $0.61B · +5.7%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 14, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue🔥 9-Quarter EPS Beat Streak
AVAH reports quarterly as a NASDAQ-listed Medical - Care Facilities company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.37
Rev. $0.36B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.37
Rev. Est.$0.36B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 6, 2026 | $0.16 | — | — | — | $0.63B | — |
| ▲ Q2 FY2026 | May 14, 2026 | $0.13 | $0.18 | +38.5% | $0.65B | $0.61B | +5.7% |
| ▲ Q1 FY2026 | Mar 19, 2026 | $0.15 | $0.17 | +10.5% | $0.66B | $0.64B | +3.0% |
| ▲ Q4 FY2025 | Nov 6, 2025 | $0.08 | $0.15 | +87.5% | $0.62B | $0.65B | -4.2% |
| ▲ Q3 FY2025 | Aug 7, 2025 | $0.04 | $0.18 | +350.0% | $0.59B | $0.54B | +9.1% |
| ▲ Q2 FY2025 | May 8, 2025 | $0.03 | $0.10 | +216.8% | $0.56B | $0.53B | +6.1% |
| ▲ Q1 FY2025 | Mar 13, 2025 | $0.00 | $0.05 | +1178.8% | $0.52B | $0.52B | +0.7% |
| ▲ Q4 FY2024 | Nov 7, 2024 | $0.01 | $0.02 | +254.0% | $0.51B | $0.50B | +1.9% |
Q3 FY2026
Aug 6, 2026
EPS Actual
—
EPS Est.
$0.16
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 14, 2026Beat
EPS Actual
$0.18
EPS Est.
$0.13
EPS Surpr.
+38.5%
Revenue
$0.65B
Q1 FY2026
Mar 19, 2026Beat
EPS Actual
$0.17
EPS Est.
$0.15
EPS Surpr.
+10.5%
Revenue
$0.66B
Q4 FY2025
Nov 6, 2025Beat
EPS Actual
$0.15
EPS Est.
$0.08
EPS Surpr.
+87.5%
Revenue
$0.62B
Q3 FY2025
Aug 7, 2025Beat
EPS Actual
$0.18
EPS Est.
$0.04
EPS Surpr.
+350.0%
Revenue
$0.59B
Q2 FY2025
May 8, 2025Beat
EPS Actual
$0.10
EPS Est.
$0.03
EPS Surpr.
+216.8%
Revenue
$0.56B
Q1 FY2025
Mar 13, 2025Beat
EPS Actual
$0.05
EPS Est.
$0.00
EPS Surpr.
+1178.8%
Revenue
$0.52B
Q4 FY2024
Nov 7, 2024Beat
EPS Actual
$0.02
EPS Est.
$0.01
EPS Surpr.
+254.0%
Revenue
$0.51B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2028 | $0.20 | $0.20 | $0.21 | 5 |
| Q4 FY2027 | $0.17 | $0.18 | $0.18 | 4 |
| Q3 FY2027 | $0.18 | $0.18 | $0.18 | 5 |
| Q2 FY2027 | $0.17 | $0.18 | $0.18 | 2 |
| Q1 FY2027 | $0.18 | $0.18 | $0.18 | 2 |
| Q4 FY2026 | $0.16 | $0.17 | $0.18 | 7 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2028 | $0.7B | $0.7B | $0.7B | 3 |
| Q4 FY2027 | $0.7B | $0.7B | $0.7B | 4 |
| Q3 FY2027 | $0.7B | $0.7B | $0.7B | 4 |
| Q2 FY2027 | $0.7B | $0.7B | $0.7B | 4 |
| Q1 FY2027 | $0.7B | $0.7B | $0.7B | 4 |
| Q4 FY2026 | $0.6B | $0.7B | $0.7B | 5 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 14, 2026 | +38.5% | $6.77 | $7.44 | +9.90% |
| ▲ Q1 FY2026 | Mar 19, 2026 | +10.5% | $6.91 | $6.34 | -8.25% |
| ▲ Q4 FY2025 | Nov 6, 2025 | +87.5% | $9.21 | $8.63 | -6.30% |
| ▲ Q3 FY2025 | Aug 7, 2025 | +350.0% | $3.89 | $5.81 | +49.36% |
| ▲ Q2 FY2025 | May 8, 2025 | +216.8% | $4.82 | $5.50 | +14.11% |
| ▲ Q1 FY2025 | Mar 13, 2025 | +1178.8% | $3.74 | $5.14 | +37.43% |
| ▲ Q4 FY2024 | Nov 7, 2024 | +254.0% | $4.81 | $5.59 | +16.22% |
| ▲ Q3 FY2024 | Aug 8, 2024 | +150.0% | $3.43 | $4.54 | +32.36% |
Q2 FY2026+9.90%
Report Date
May 14, 2026
EPS Beat/Miss
+38.5%
Price Before
$6.77
Price After
$7.44
Q1 FY2026-8.25%
Report Date
Mar 19, 2026
EPS Beat/Miss
+10.5%
Price Before
$6.91
Price After
$6.34
Q4 FY2025-6.30%
Report Date
Nov 6, 2025
EPS Beat/Miss
+87.5%
Price Before
$9.21
Price After
$8.63
Q3 FY2025+49.36%
Report Date
Aug 7, 2025
EPS Beat/Miss
+350.0%
Price Before
$3.89
Price After
$5.81
Q2 FY2025+14.11%
Report Date
May 8, 2025
EPS Beat/Miss
+216.8%
Price Before
$4.82
Price After
$5.50
Q1 FY2025+37.43%
Report Date
Mar 13, 2025
EPS Beat/Miss
+1178.8%
Price Before
$3.74
Price After
$5.14
Q4 FY2024+16.22%
Report Date
Nov 7, 2024
EPS Beat/Miss
+254.0%
Price Before
$4.81
Price After
$5.59
Q3 FY2024+32.36%
Report Date
Aug 8, 2024
EPS Beat/Miss
+150.0%
Price Before
$3.43
Price After
$4.54
Avg Beat Reaction+18.10%
Beat Rate8 / 8 quarters
Largest Move+49.36% (Q3 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: AVAH ends December
Aveanna Healthcare Holdings Inc. (AVAH) most recently reported earnings on May 14, 2026 for Q2 FY2026, posting EPS of $0.18 — beating the analyst consensus of $0.13 by +38.5%. AVAH has beaten EPS estimates for 9 consecutive quarters. The next AVAH earnings date is expected around September 1, 2026.
Each quarter, investors track AVAH earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. AVAH revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
AVAH's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
AVAH earnings · 5 questionsAveanna Healthcare Holdings Inc.'s next earnings report is expected around September 1, 2026. AVAH typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; AVAH historically reports after market close (AMC).
AVAH earnings datewhen is AVAH earningsAVAH next earnings datewhen does AVAH report earningsAVAH earnings calendar
▸ Source: FMP · Aveanna Healthcare Holdings Inc. SEC filings · US GAAP · Aveanna Healthcare Holdings Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026